uspto.gov
Skip over navigation

2401 Introduction [R-07.2022]

This chapter provides guidance on the practices and procedures pertaining to the rules for deposits of biological materials for patent purposes (37 CFR 1.801 - 1.809 ) and the rules for the requirements for patent applications containing nucleotide sequence and/or amino acid sequence disclosures (37 CFR 1.821 - 1.825 and 37 CFR 1.831 - 1.835).

[top]

 

United States Patent and Trademark Office
This page is owned by Patents.
Last Modified: 02/16/2023 12:58:23